It was reported on (b)(6) 2023, a mitraclip procedure was performed to treat degenerative mitral regurgitation (mr) with a grade of 4.One xtw clip was implanted, reducing mr to a grade of 2.Roughly one year post procedure, the patient returned to the hospital for a follow up with a symptom of shortness of breath.Echocardiography showed the implanted clip detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachment/slda), causing mr to return to a grade of 4.It was noted tissue damage potentially occurred.On (b)(6) 2024, an additional mitraclip procedure was performed.To stabilize the slda, two additional xt clips were implanted, reducing mr to a grade of 1.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no similar complaints from the lot.All available information was investigated, and the reported slda appears to be related to patient conditions as the physician believed there was a change in anatomy.Unspecified tissue injury and mitral valve insufficiency/ regurgitation (recurrent) resulting in dyspnea appear to be due to the slda.Mitral regurgitation, dyspnea and tissue damage are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|